Friday 6 November 2026
Export ASPN’s income statement to Excel — free account
Aspen Aerogels, Inc.
ASPN Basic Materials Specialty Chemicals
Aspen Aerogels, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $271.1 million, down 40.1% from fiscal 2024.
- Revenue
- +16.7%
- EPS
- −62.5%
- Free cash flow
- −93.1%
- Total debt
- −79.6%
Quarter to September 2026, against a year earlier
4.90
0.26
−5.04%
Follow ASPN
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 5 Nov | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
4 | 4 | 4 | 4 |
| (91.64%) | (42.40%) | (50.36%) | (53.16%) | ||
| (59.85%) | (23.20%) | (27.49%) | (29.43%) | ||
ROIC |
(126.54%) | (47.78%) | (58.13%) | (131.54%) | |
Return on Tangible Assets |
(139.91%) | (43.09%) | (54.06%) | (59.95%) | |
Average Days of Receivables |
47.49 | 57.76 | 72.75 | 106.05 | |
Free Cash Flow per Share |
(0.06) | 0.43 | 0.41 | 0.35 | |
Free Cash Flow |
(4.58) | 35.57 | 34.38 | 28.86 | |
Capital Expenditures |
(37.45) | (25.82) | (14.73) | (1.47) | |
| Other line items | |||||
Cash ROIC |
(0.91%) | 7.38% | 7.82% | 8.17% | |
Accounts Receivable Turnover |
3.76 | 4.05 | 3.47 | 3.26 | |
Accounts Payable Turnover |
7.82 | 7.58 | 8.20 | 7.43 | |
Inventory Turnover |
5.25 | 4.62 | 4.91 | 5.78 | |
Average Days of Payables |
21.47 | 24.50 | 38.89 | 64.92 | |
Days of Inventory on Hand |
62.02 | 55.89 | 51.87 | 51.16 | |
Tax Rate |
0.01 | 0.01 | 0.01 | 0.01 | |
Research and Development Expense of Revenue |
4.95% | 5.13% | 5.55% | 5.22% | |
Selling, General and Administrative Expense of Revenue |
30.97% | 36.70% | 41.40% | 39.29% | |
Share Based Compensation of Revenue |
3.18% | 3.71% | 3.76% | 3.29% | |
Interest Coverage |
— | (8.93) | (10.30) | — | |
Operating CF/Net income |
(0.08) | (0.55) | (0.39) | (0.23) | |
Depreciation/Fixed assets |
0.50 | 0.53 | 0.58 | 0.00 | |
Capex/Depreciation |
(0.77) | (0.52) | (0.30) | 0.00 | |
Revenue per Share |
3.29 | 2.78 | 2.44 | 2.58 | |
Operating CF per Share |
0.40 | 0.74 | 0.59 | 0.37 | |
Capex per Share |
(0.45) | (0.31) | (0.18) | (0.02) | |
Capex to Sales |
0.14 | 0.11 | 0.07 | 0.01 |
Columns are period end dates · fundamentals updated 5 Nov 2026